Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect of a Change in Accounting Principle	Common Stock	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect of a Change in Accounting Principle	Retained Earnings	Retained Earnings Cumulative Effect of a Change in Accounting Principle	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2019			51,277,000
Balance at beginning of period (in shares) at Dec. 31, 2019				(9,145,000)
Balance at beginning of period at Dec. 31, 2019	$ 845,254	$ (264)	$ 51	$ (185,074)	$ 780,931		$ 258,792	$ (264)	$ (9,446)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	32,194						32,194
Other comprehensive income (loss)	3,924								3,924
Share-based compensation	44,697				44,697
Issuance of common stock under employee stock plans (in shares)			1,400,000
Issuance of common stock under employee stock plans	54,270		$ 2		54,268
Tax payments related to restricted stock units	(8,738)				(8,738)
Stock repurchases (in shares)				(749,000)
Stock repurchases	(53,035)			$ (53,035)
Equity component of convertible senior note issuance, net of issuance costs	97,830				97,830
Purchase of convertible note hedge	(100,625)				(100,625)
Sale of warrants	51,290				51,290
Tax benefits related to convertible senior notes and convertible note hedge	706				706
Balance at end of period (in shares) at Dec. 31, 2020			52,677,000
Balance at end of period (in shares) at Dec. 31, 2020				(9,894,000)
Balance at end of period at Dec. 31, 2020	967,503		$ 53	$ (238,109)	920,359		290,722		(5,522)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	77,849						77,849
Other comprehensive income (loss)	(2,885)								(2,885)
Share-based compensation	53,160				53,160
Issuance of common stock under employee stock plans (in shares)			1,396,000
Issuance of common stock under employee stock plans	67,348		$ 1		67,347
Tax payments related to restricted stock units	$ (16,286)				(16,286)
Balance at end of period (in shares) at Dec. 31, 2021	44,179,000		54,073,000
Balance at end of period (in shares) at Dec. 31, 2021	(9,894,000)			(9,894,000)
Balance at end of period at Dec. 31, 2021	$ 1,146,689	$ (56,233)	$ 54	$ (238,109)	1,024,580	$ (72,742)	368,571	$ 16,509	(8,407)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06 [Member]
Net income	$ 5,648						5,648
Other comprehensive income (loss)	(8,680)								(8,680)
Share-based compensation	68,247				68,247
Issuance of common stock under employee stock plans (in shares)			957,000
Issuance of common stock under employee stock plans	40,182		$ 1		40,181
Tax payments related to restricted stock units	(13,506)				(13,506)
Stock repurchases (in shares)				(389,000)
Stock repurchases	$ (52,210)			$ (52,210)
Balance at end of period (in shares) at Dec. 31, 2022	44,747,000		55,030,000
Balance at end of period (in shares) at Dec. 31, 2022	(10,283,000)			(10,283,000)
Balance at end of period at Dec. 31, 2022	$ 1,130,137		$ 55	$ (290,319)	$ 1,046,760		$ 390,728		$ (17,087)